185 related articles for article (PubMed ID: 10634819)
1. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.
Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):204-9. PubMed ID: 10634819
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease.
Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
Atherosclerosis; 2005 Nov; 183(1):157-62. PubMed ID: 16216595
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.
Wu R; Nityanand S; Berglund L; Lithell H; Holm G; Lefvert AK
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3159-63. PubMed ID: 9409306
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.
Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T
Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816
[TBL] [Abstract][Full Text] [Related]
6. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men.
Vaarala O; Mänttäri M; Manninen V; Tenkanen L; Puurunen M; Aho K; Palosuo T
Circulation; 1995 Jan; 91(1):23-7. PubMed ID: 7805207
[TBL] [Abstract][Full Text] [Related]
7. Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytes.
Craig WY; Poulin SE; Neveux LM; Palomaki GE; Dostal-Johnson DA; Ledue TB; Ritchie RF
J Autoimmun; 1995 Oct; 8(5):713-26. PubMed ID: 8579726
[TBL] [Abstract][Full Text] [Related]
8. Using oxidized low-density lipoprotein autoantibodies to predict restenosis after balloon angioplasty in patients with acute myocardial infarction.
Huang CH; Chang CC; Huang CS; Kuo CL; Chen CP; Hsia CH; Chang YM; Chen HT; Feng CC; Lin LS; Yang PT; Tsai CD; Lin CS; Liu CS
PLoS One; 2013; 8(10):e74726. PubMed ID: 24098346
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies and myocardial infarction.
Vaarala O
Lupus; 1998; 7 Suppl 2():S132-4. PubMed ID: 9814690
[TBL] [Abstract][Full Text] [Related]
10. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers.
Fickl H; Van Antwerpen VL; Richards GA; Van der Westhuyzen DR; Davies N; Van der Walt R; Van der Merwe CA; Anderson R
Atherosclerosis; 1996 Jul; 124(1):75-81. PubMed ID: 8800495
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to oxidized low-density lipoprotein in coronary artery disease.
Sherer Y; Tenenbaum A; Blank M; Shemesh J; Harats D; Fisman EZ; Praprotnik S; Motro M; Shoenfeld Y
Am J Hypertens; 2001 Feb; 14(2):149-54. PubMed ID: 11243306
[TBL] [Abstract][Full Text] [Related]
15. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty.
George J; Harats D; Bakshi E; Adler Y; Levy Y; Gilburd B; Shoenfeld Y
Immunol Lett; 1999 Jun; 68(2-3):263-6. PubMed ID: 10424430
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against phospholipids and oxidized LDL in alcoholic patients.
Zima T; Fialová L; Mikulíková L; Malbohan IM; Popov P; Nespor K
Physiol Res; 1998; 47(5):351-5. PubMed ID: 10052604
[TBL] [Abstract][Full Text] [Related]
18. The autoantibody expression against different source of oxidized low density lipoprotein in patients with acute myocardial infarction.
Wang TC; Hsu CC; Chin YP; Lin YL
Thromb Res; 2002 Aug; 107(3-4):175-9. PubMed ID: 12431486
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
20. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
